Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 30.26B | 43.15B | 35.87B | 39.33B | 49.42B |
Gross Profit | 3.99B | 8.25B | 4.63B | 5.20B | 3.40B |
EBITDA | 2.06B | 6.35B | 2.56B | 4.09B | 1.50B |
Net Income | 560.00M | 4.37B | 1.18B | 2.77B | 662.00M |
Balance Sheet | |||||
Total Assets | 58.84B | 59.56B | 55.49B | 61.50B | 66.02B |
Cash, Cash Equivalents and Short-Term Investments | 6.35B | 11.72B | 7.63B | 9.94B | 4.35B |
Total Debt | 5.41B | 4.92B | 9.10B | 15.72B | 22.43B |
Total Liabilities | 25.22B | 27.06B | 28.20B | 37.02B | 44.70B |
Stockholders Equity | 33.61B | 32.50B | 27.29B | 24.47B | 21.32B |
Cash Flow | |||||
Free Cash Flow | -5.77B | 8.26B | 5.22B | 12.10B | -408.00M |
Operating Cash Flow | -4.86B | 8.93B | 5.92B | 12.95B | 24.00M |
Investing Cash Flow | -576.00M | 2.58B | -652.00M | -4.03B | -128.00M |
Financing Cash Flow | -14.00M | -4.62B | -8.26B | -6.48B | -695.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥28.91B | 12.31 | 4.39% | 4.40% | 18.82% | ||
79 Outperform | ¥60.02B | 14.05 | 1.45% | 37.64% | 69.78% | ||
79 Outperform | ¥19.79B | 8.11 | 4.92% | 16.52% | 41.05% | ||
65 Neutral | $10.86B | 15.57 | 5.28% | 1.92% | 3.13% | -27.76% | |
62 Neutral | ¥13.95B | 24.93 | 2.47% | -29.89% | -87.19% | ||
― | $203.87M | 1.03 | 10.04% | 1.91% | ― | ― | |
65 Neutral | ¥34.13B | 25.33 | 1.97% | 0.68% | -22.82% |